News

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...
In a real-world setting, the administration of oral semaglutide leads to a significant reduction in the urinary ...
Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...
Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...
A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...
Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide.
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
Navvi, the cash‑pay digital prescribing platform founded by physicians, today announced the launch of its All‑Specialty Compound Medication Marketplace and a formal call for additional accredited ...
GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...